Colgate-Palmolive Company CL
Verdict: Hold. Fair value $80.40 against a price of $76.93 on 6 Jan 2026, 5% above the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins.
Main risks
- Extremely high Debt-to-Equity ratio (40.5x) due to a near-zero equity base, creating significant balance sheet risk if cash flows falter.
- Revenue growth decelerated sharply in the most recent year (3.3%) from the prior year (8.3%), indicating a potential slowdown.
- Inability to calculate key metrics (margins, interest coverage, historical ROIC) due to missing data, reducing confidence in a full assessment.
- Intense competitive environment
- Overhang: The primary overhang is the 'Analysts Split on 2026 Staples Outlook,' indicating broader m...